# Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19

> **NCT04964414** · PHASE1,PHASE2 · TERMINATED · sponsor: **Amanda Stapleton** · enrollment: 20 (actual)

## Conditions studied

- Dysosmia
- Anosmia
- Covid19

## Interventions

- **OTHER:** Smell Retraining
- **DRUG:** Budesonide

## Key facts

- **NCT ID:** NCT04964414
- **Lead sponsor:** Amanda Stapleton
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-09-30
- **Primary completion:** 2023-01-13
- **Final completion:** 2023-03-29
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Slow recruitment
- **Last updated:** 2024-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04964414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04964414, "Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04964414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*